Motilal Oswal has come out with its earning estimates on Pharmaceuticals sector for the quarter ended March 2011. According to the research firm, Biocon March quarter sales are expected to go up by 6.5% at Rs 699.4 crore, year-on-year, (YoY) basis.
The company's net profit is expected to go up by 9.5% at Rs 88.3 crore on YoY basis.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
